Foster 100/6
Beclometasone + Formetrol
Therapeutic Indication:
- Asthma: Foster is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate, patients not adequately controlled with inhaled corticosteroids and as-needed inhaled rapid-acting beta2-agonist, or for patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.
- COPD: Symptomatic treatment of patients with severe COPD (FEV1 < 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.
- Composition: Beclometasone Dipropionate Anhydrous 100 mcg/Actuation, Formoterol Fumarate Dihydrate 6 mcg/Actuation.
- Pharmaceutical Form: Pressurized Solution for inhalation.
- Method of Administration: Inhalation.
- How Supplied: Single Inhaler, 120 Actuations.
- Manufacturer: Chiesi Farmaceutici, Italy.